Back to News
Dec 3, 2025 12:30 PM

AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

The U.K. government is bringing together senior pharmaceutical executives to help chart a new direction for the country's drug-pricing system.

Whitehall officials will invite reps from AstraZeneca Plc (NASDAQ:AZN) and GSK Plc (NYSE:GSK) to join the panel.

Sky News reported that the group will analyze successors to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG).

VPAG is set to expire in roughly three years.

The initiative reflects rising tensions. Pharmaceutical manufacturers have voiced concerns that the existing VPAG structure ...